Squamous cell carcinoma is the most common head and neck cancer. This review describes the state-of-the-art computerised tomography and magnetic resonance imaging protocols of the neck and the normal larynx anatomy, and provides a practical approach for the diagnosis and staging of laryngeal squamous cell carcinoma.
KeberleMTschammlerABerningK. Spiral CT of the neck: When do neck malignancies delineate best during contrast enhancement?Eur Radiol2001; 11: 1986–1990.
10.
GroellRDoerflerOSchafflerGJ. Contrast-enhanced helical CT of the head and neck: Improved conspicuity of squamous cell carcinoma on delayed scans. AJR Am J Roentgenol2001; 176: 1571–1575.
ZbärenPCaversaccioMThoenyHC. Radionecrosis or tumor recurrence after radiation of laryngeal and hypopharyngeal carcinomas. Otolaryngol Head Neck Surg2006; 135: 838–843.
13.
Abdel RazekAAKandeelAYSolimanN. Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol2007; 28: 1146–1152.
14.
KeberleMKennWHahnD. Current concepts in imaging of laryngeal and hypopharyngeal cancer. Eur Radiol2002; 12: 1672–1683.
15.
KataokaMUedaHKoyamaT. Contrast-enhanced volumetric interpolated breath-hold examination compared with spin-echo T1-weighted imaging of head and neck tumors. AJR Am J Roentgenol2005; 184: 313–319.
16.
ThoenyHCDe KeyzerFKingAD. Diffusion-weighted MR imaging in the head and neck. Radiology2012; 263: 19–32.
17.
Edge SB, Byrd DR, Compton CC, et al. (eds) AJCC cancer staging manual. 7th ed. 2010. New York: Springer, 2010.
18.
BeckerMZbärenPLaengH. Neoplastic invasion of the laryngeal cartilage: Comparison of MR imaging and CT with histopathologic correlation. Radiology1995; 194: 661–669.
19.
BeckerMZbärenPCasselmanJW. Neoplastic invasion of laryngeal cartilage: Reassessment of criteria for diagnosis at MR imaging. Radiology2008; 249: 551–559.
20.
RobbinsKTClaymanGLevinePA. American Head and Neck Society; American Academy of Otolaryngology–Head and Neck Surgery. Neck dissection classification update: Revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology–Head and Neck Surgery. Arch Otolaryngol Head Neck Surg2002; 128: 751–758.
21.
HoangJKVankaJLudwigBJ. Evaluation of cervical lymph nodes in head and neck cancer with CT and MRI: Tips, traps, and a systematic approach. AJR Am J Roentgenol2013; 200: W17–W25.
22.
SchwartzLHBogaertsJFordR. Evaluation of lymph nodes with RECIST 1.1. Eur J Cancer2009; 45: 261–267.
23.
Van den BrekelMWStelHVCastelijnsJA. Cervical lymph node metastasis: Assessment of radiologic criteria. Radiology1990; 177: 379–384.
24.
SteinkampHJCornehlMHostenN. Cervical lymphadenopathy: Ratio of long- to short-axis diameter as a predictor of malignancy. Br J Radiol1995; 68: 266–270.
25.
De BondtRBHoeberigsMCNelemansPJ. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology2009; 51: 183–192.
26.
HolzapfelKDuetschSFauserC. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol2009; 72: 381–387.
27.
VandecaveyeVDe KeyzerFVander PoortenV. Head and neck squamous cell carcinoma: Value of diffusion-weighted MR imaging for nodal staging. Radiology2009; 251: 134–146.
28.
WangJTakashimaSTakayamaFKawakamiS. Head and neck lesions: Characterization with diffusion-weighted echo-planar MR imaging. Radiology2001; 220: 621–630.
29.
YousemDMHatabuHHurstRW. Carotid artery invasion by head and neck masses: Prediction with MR imaging. Radiology1995; 195: 715–720.
30.
AlviAJohnsonJT. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck1997; 19: 500–505.
31.
FerlitoAShahaARSilverCE. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec2001; 63: 202–207.
32.
LjumanovicRLangendijkJAHoekstraOS. Distant metastases in head and neck carcinoma: Identification of prognostic groups with MR imaging. Eur J Radiol2006; 60: 58–66.